WHO ICTRP trial
Add-on effects of statin in simeprevir, peginterferon plus ribavirin combination…
JPRN-UMIN000012878 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000012878 |
|---|---|
| Public title | Add-on effects of statin in simeprevir, peginterferon plus ribavirin combination therapy for chronic hepatitis C. |
| Scientific title | Add-on effects of statin in simeprevir, peginterferon plus ribavirin combination therapy for chronic hepatitis C. - Statin add onto simeprevir, peginterferon plus ribavirin therapy |
| Primary sponsor | Hokkaido University Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Chronic hepatitis C |
| Interventions | fluvastatin, simeprevir, peginterferon and ribavirin simeprevir, peginterferon and ribavirin |
| Registration date | Jan 22, 2014 |
| Target size | 76 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: